4701 - 4710 of 9156 Results
Title
Year
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 44
-
OPENTitle: Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 2Start Page: 441End Page: 449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15165Citation Count: 42
- The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging study2021RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
- Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease2021RESTRICTEDTitle: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 6Start Page: 550End Page: 565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1Citation Count: 52
- RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease2021RESTRICTEDTitle: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 8Start Page: 734End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6Citation Count: 103
- Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker2022OPENTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 54
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 138
- Aducanumab: look before leaping2021RESTRICTEDTitle: Aducanumab: look before leapingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 9Start Page: 1499End Page: 1499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5Citation Count: 13
- Deep brain stimulation for obsessive–compulsive disorder: a crisis of access2022OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 81
- Tracer development for PET imaging of proteinopathies2022RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Citation Count: 0